Journal of Hepatology
Volume 51, Issue 5 , Pages 881-889, November 2009

Concurrent induction of necrosis, apoptosis, and autophagy in ischemic preconditioned human livers formerly treated by chemotherapy

  • Marie-Charlotte Domart

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service de Biochimie et Biologie Moléculaire, 14 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
    • These authors contributed equally to this work.
  • ,
  • Davide Degli Esposti

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service de Biochimie et Biologie Moléculaire, 14 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
    • Laboratoire de Biochimie et Biologie Cellulaire, Faculté de Pharmacie, Châtenay-Malabry Cedex, France
    • These authors contributed equally to this work.
  • ,
  • Mylène Sebagh

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service d’Anatomie Pathologique, Inserm U785, Université Paris-Sud 11, Institut André Lwoff, Villejuif Cedex, France
  • ,
  • Natalia Olaya

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service de Biochimie et Biologie Moléculaire, 14 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
  • ,
  • Francis Harper

      Affiliations

    • Institut André Lwoff, UPR-1983, Laboratoire Réplication de l’ADN et Ultrastructure du Noyau, Villejuif, France
  • ,
  • Gérard Pierron

      Affiliations

    • Institut André Lwoff, UPR-1983, Laboratoire Réplication de l’ADN et Ultrastructure du Noyau, Villejuif, France
  • ,
  • Brigitte Franc

      Affiliations

    • AP-HP, Hôpital Ambroise Paré, Service d’Anatomie Pathologique, Boulogne-Billancourt, Université Versailles/St Quentin, PRES Universud-Paris, Versailles, France
  • ,
  • Kenneth K. Tanabe

      Affiliations

    • Division of Surgical Oncology, Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA
  • ,
  • Brigitte Debuire

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service de Biochimie et Biologie Moléculaire, 14 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
  • ,
  • Daniel Azoulay

      Affiliations

    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
    • AP-HP, Hôpital Paul Brousse, Centre Hépatobiliaire, Université Paris-Sud 11, Villejuif Cedex, France
  • ,
  • Catherine Brenner

      Affiliations

    • CNRS UMR 8159, Université Versailles/St. Quentin, PRES Universud-Paris, Versailles, France
  • ,
  • Antoinette Lemoine

      Affiliations

    • AP-HP, Hôpital Paul Brousse, Service de Biochimie et Biologie Moléculaire, 14 Avenue Paul Vaillant Couturier, 94804 Villejuif Cedex, France
    • Inserm U602, Institut André Lwoff-IFR89, Université Paris-Sud 11, PRES Universud-Paris, Villejuif, France
    • Laboratoire de Biochimie et Biologie Cellulaire, Faculté de Pharmacie, Châtenay-Malabry Cedex, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 1 45593693; fax: +33 1 45593625.

Received 18 February 2009; received in revised form 26 May 2009; accepted 17 June 2009. published online 14 August 2009.

Associate Editor: P.-A. Clavien

Background/Aims

Liver pathology induced by chemotherapy (steatosis or vascular injury) is known to increase the liver’s sensitivity to ischemia/ reperfusion (I/R) injury, thereby increasing morbidity and mortality after liver resection. Our aim was to assess whether ischemic preconditioning (IP) reduces I/R injury to livers with chemotherapy-induced pathology.

Methods

We analyzed a series of livers from patients treated with chemotherapy for colorectal cancer who underwent IP (n=30) or not (n=31) before hepatectomy. All but one of the livers exhibited chemotherapy-induced steatosis and/ or peliosis before the I/R insult.

Results

Necrosis was less frequent (p=0.038) in livers with IP than in the others. IP had no influence on apoptosis as assessed by terminal transferase uridyl nick-end labeling (TUNEL) assay or caspase-3, -8 and -9 expression. IP induced a twofold increase in B-cell leukemia/ lymphoma 2 (Bcl-2; p<0.05), which was localized to hepatocytes of centrolobular and peliotic areas and colocalized with the autophagy protein beclin-1 in livers with IP, suggesting their coordinated role in autophagy. Increased expression of the phosphorylated Bcl-2 was observed in preconditioned livers and was associated with a decreased immunoprecipitation of beclin-1 and the increased expression of light chain 3 type II (LC3-II). The increased number of autophagic vacuoles seen by electron microscopy confirmed an association of autophagy in chemotherapy-injured livers following IP. However, the differences in protein expression were not reflected in postresection liver-injury tests or measure of patient morbidity.

Conclusions

IP is associated with a reduction in necrosis of hepatocytes already damaged by chemotherapy and an activation of autophagy. Bcl-2 and beclin-1 could be major targets in the regulation of cell death during I/R injury.

Keywords: Cell death, Ischemia/reperfusion, Ischemic preconditioning, Chemotherapy, Bcl-2, Beclin-1, Autophagy, Liver

Abbreviations: ATP, adenosine triphosphate, BCIP/NBT, 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium, Bcl-2, B-cell leukemia/lymphoma 2, IP, ischemic preconditioning, I/R, ischemia/reperfusion, LC3-II, light chain 3 type II, SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis, TUNEL, terminal transferase uridyl nick-end labeling

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors who have taken part in this study declared that they do not have anything to disclose regarding funding from industry or conflict of interest with respect to this manuscript.

PII: S0168-8278(09)00519-4

doi:10.1016/j.jhep.2009.06.028

Journal of Hepatology
Volume 51, Issue 5 , Pages 881-889, November 2009